Research Article

Design of a Machine Learning-Assisted Wearable Accelerometer-Based Automated System for Studying the Effect of Dopaminergic Medicine on Gait Characteristics of Parkinson’s Patients

Table 1

Details of the PD group.

M/F (n = 48)25/23
Age70.61 ± 9.51
UPDRS part III20.9 ± 12.31
H&Y stage2.10 ± 0.74
Disease duration (months)35.49 ± 27.07
Timed-up and go20.87 ± 15.78
Tinetti gait scale9.86 ± 2.56